Ergoteles’s Thermo Fisher Scientific TMO Stock Holding History

Ergoteles’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,626	Closed	-$2M	–	1751
2022 Q4	$2M	Sell	3,626 -206	-5%	-$109K	0.07%	280
2022 Q3	$1.94M	Buy	+3,832	New	+$2.14M	0.07%	283
2022 Q2	–	Sell	-4,321	Closed	-$2.55M	–	2001
2022 Q1	$2.55M	Buy	4,321 +1,582	+58%	+$909K	0.1%	218
2021 Q4	$1.83M	Buy	+2,739	New	+$1.71M	0.07%	269
2021 Q3	–	Sell	-53,918	Closed	-$27.2M	–	1663
2021 Q2	$27.2M	Buy	+53,918	New	+$25.4M	0.62%	21
2021 Q1	–	Sell	-4,520	Closed	-$2.1M	–	1055
2020 Q4	$2.1M	Buy	+4,520	New	+$2.12M	0.07%	242

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Ergoteles's TMO Position: Q1 2023 in Review

Ergoteles sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 3,626 shares — an estimated $2M sold.

Ergoteles first reported a position in TMO in Q4 2020 and held it in 6 quarters. The position peaked at $27.2M in Q2 2021. 2,385 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

Ergoteles reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 3,626 Thermo Fisher Scientific shares in Q1 2023, an estimated $2M.
Ergoteles first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 6 quarters.
Ergoteles's Thermo Fisher Scientific position peaked at $27.2M in Q2 2021.
2,385 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.